Trials / Terminated
TerminatedNCT04264754
Characterization of Methylation Patterns in Hepatocellular Carcinoma
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Nucleix Ltd. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This study is being performed as part of the development process of the Liver EpiCheck test which includes the identification of different methylation profiles in HCC (hepatocellular carcinoma) patients compare to cancer free control in blood samples
Detailed description
This is a prospective, multi-center, observational study aimed to collect blood samples and de-identified clinical data from subjects diagnosed with HCC (cases arm) and subjects with high risk for HCC which are undergoing routine surveillance for HCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood collection | Peripheral blood will be collected via routine venipuncture procedure |
Timeline
- Start date
- 2018-02-13
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
- First posted
- 2020-02-11
- Last updated
- 2021-05-06
Locations
5 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT04264754. Inclusion in this directory is not an endorsement.